STEVENSON, Md., Nov. 11, 2016 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Agria Corporation (NYSE:GRO) (“Agria” or the “Company”) American Depositary Shares (“ADSs”) between December 16, 2011 and November 4, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 9, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the Class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the Class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Agria ADSs during the Class Period. Members of the Class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that Defendants were conducting large volume trading to artificially inflate the price of Agria’s ADSs to meet the New York Stock Exchange’s (“NYSE”) listing standards and to avoid being delisted, and Agria lacked sufficient internal controls over financial reporting.
According to the complaint, following a November 4, 2016 press release announcing that the NYSE decided to commence proceedings to delist Agria’s ADSs and that the Company had received a subpoena from the Securities and Exchange Commission regarding historic and ongoing business operations, the value of Agria ADSs declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Agria ADSs purchased on or after December 16, 2011 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
California DMV Proposes New Safety Rules for Autonomous Vehicles After Waymo Incidents
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Boeing Wins $2.04B U.S. Air Force Contract for B-52 Engine Replacement Program
Brazilian Oil Workers’ Strike Continues as Key Petrobras Union Rejects Proposal
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
FDA Approves Mitapivat for Anemia in Thalassemia Patients
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions 



